Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumors · Relapsed/Refractory B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Shanghai Jiao Tong University School of Medicine-Ruijin Hospital, Shanghai, Shanghai Municipality, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）

Solid Tumor · Lymphoma

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Aurora, United States · Denver, United States

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor · Non-Small-Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · Atlanta, United States

GTB-5550 in Advanced Solid Tumors

Tri-specific Killer Engager · Solid Tumor · Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States